We report a case of subcutaneous Sweet syndrome in a pregnant woman that was initially believed to be cellulitis. She was admitted after failure of symptom resolution following multiple oral antibiotics as an outpatient. Her rash continued to progress, and she became nauseous with a lack of appetite. Infectious disease, rheumatology, and dermatology were consulted. Skin biopsies were taken, and while awaiting results, due to continued disease progression despite broad-spectrum antibiotic coverage, IV steroids were started with rapid resolution. Eventual biopsy results showed a dense neutrophilic infiltrate in the subcutaneous fat in a lobular distribution without evidence of vasculitis, confirming a diagnosis of subcutaneous Sweet syndrome. This disease is exceedingly rare in pregnant patients, with few reported cases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516325PMC
http://dx.doi.org/10.7759/cureus.17999DOI Listing

Publication Analysis

Top Keywords

subcutaneous sweet
12
sweet syndrome
12
subcutaneous
4
syndrome presenting
4
presenting cellulitis
4
cellulitis pregnant
4
pregnant female
4
female report
4
report case
4
case subcutaneous
4

Similar Publications

Introduction: Bortezomib is a reversible proteasome inhibitor that is a first-line chemotherapeutic agent for multiple myeloma. Bortezomib can be administered intravenously or subcutaneously with similar efficacy. Subcutaneous administration has fewer side effects.

View Article and Find Full Text PDF

Background: The aims of this review were to identify and to analyze the clinical studies that used subcutaneous injections of dextrose for treating musculoskeletal pain, in order to establish an overview.

Methods: A systematic search was carried out in scientific databases including Web of Science, Cochrane Central Register of Controlled Trials, PUBMED and other sources, up until March 2024. We included clinical studies that used subcutaneous injections of dextrose in the treatment of individuals with musculoskeletal pain associated with tendinopathies, enthesopathy, osteoarthritis, ligament sprains, muscle strains or bursitis of various locations.

View Article and Find Full Text PDF

Subcutaneous Sweet Syndrome With Vasculitis Features: Case Report and Review.

Am J Dermatopathol

February 2025

Department of Emergency, The First Hospital of Jilin University, Changchun, Jilin Province, China.

Background: Subcutaneous Sweet Syndrome (SSS) is a rare variant of Sweet Syndrome characterized by neutrophilic infiltration of subcutaneous adipose tissue without vasculitis. The presence of vasculitis in SSS is uncommon and poses diagnostic challenges.

Case Presentation: A 38-year-old female presented with a one-year history of recurrent painful erythematous nodules on her limbs and face.

View Article and Find Full Text PDF
Article Synopsis
  • * Subcutaneous Sweet's syndrome (SSS) is a rare variant presenting as tender nodules resembling EN and can complicate diagnosis due to similar symptoms like fever and elevated inflammatory markers.
  • * In a specific case study, a patient had a painful thigh lesion with distinctive histopathological features that indicated SSS rather than EN despite the similarities between the two conditions.
View Article and Find Full Text PDF

The present study aimed to (a) assess normal-weight obesity (NWO) and general obesity prevalence among women of different ages residing in urban areas, (b) evaluate subcutaneous fat thickness (SFT) in women with NWO, (c) establish SFT cutoff points for distinguishing NWO, and (d) explore eating habits linked to NWO. This cross-sectional study with 184 women aged 18-65 with NWO, normal weight without obesity (NWNO), overweight and general obesity included evaluation of body composition, SFT assessment using 2.5 MHz A-mode ultrasound (ISAK protocol, 7 sites) and lifestyle inquiries.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!